Sean Lee
Stock Analyst at HC Wainwright & Co.
(4.10)
# 489
Out of 4,944 analysts
88
Total ratings
33.33%
Success rate
24.47%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MYO Myomo | Maintains: Buy | $9.5 → $5 | $1.15 | +334.78% | 6 | Aug 12, 2025 | |
| KZIA Kazia Therapeutics | Maintains: Buy | $2 → $13 | $8.50 | +52.94% | 5 | Jul 10, 2025 | |
| SENS Senseonics Holdings | Maintains: Buy | $1.1 → $1.4 | $0.48 | +193.19% | 2 | Jul 8, 2025 | |
| PSTV Plus Therapeutics | Maintains: Buy | $5.5 → $3 | $0.62 | +383.87% | 12 | Jun 27, 2025 | |
| CASI CASI Pharmaceuticals | Reiterates: Buy | $4 | $1.83 | +118.58% | 9 | May 19, 2025 | |
| CTSO Cytosorbents | Reiterates: Neutral | $1 | $1.07 | -6.54% | 13 | May 15, 2025 | |
| VSTM Verastem | Maintains: Buy | $10 → $14 | $8.35 | +67.66% | 14 | May 9, 2025 | |
| DWTX Dogwood Therapeutics | Upgrades: Buy | $10 | $4.77 | +109.64% | 1 | Apr 23, 2025 | |
| ATEC Alphatec Holdings | Reiterates: Buy | $20 | $15.86 | +26.10% | 12 | Apr 14, 2025 | |
| MNPR Monopar Therapeutics | Reiterates: Buy | $40 | $34.64 | +15.47% | 10 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $4.63 | +137.58% | 3 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $1.03 | +2,812.90% | 1 | Dec 5, 2022 |
Myomo
Aug 12, 2025
Maintains: Buy
Price Target: $9.5 → $5
Current: $1.15
Upside: +334.78%
Kazia Therapeutics
Jul 10, 2025
Maintains: Buy
Price Target: $2 → $13
Current: $8.50
Upside: +52.94%
Senseonics Holdings
Jul 8, 2025
Maintains: Buy
Price Target: $1.1 → $1.4
Current: $0.48
Upside: +193.19%
Plus Therapeutics
Jun 27, 2025
Maintains: Buy
Price Target: $5.5 → $3
Current: $0.62
Upside: +383.87%
CASI Pharmaceuticals
May 19, 2025
Reiterates: Buy
Price Target: $4
Current: $1.83
Upside: +118.58%
Cytosorbents
May 15, 2025
Reiterates: Neutral
Price Target: $1
Current: $1.07
Upside: -6.54%
Verastem
May 9, 2025
Maintains: Buy
Price Target: $10 → $14
Current: $8.35
Upside: +67.66%
Dogwood Therapeutics
Apr 23, 2025
Upgrades: Buy
Price Target: $10
Current: $4.77
Upside: +109.64%
Alphatec Holdings
Apr 14, 2025
Reiterates: Buy
Price Target: $20
Current: $15.86
Upside: +26.10%
Monopar Therapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $40
Current: $34.64
Upside: +15.47%
Mar 26, 2025
Reiterates: Buy
Price Target: $11
Current: $4.63
Upside: +137.58%
Dec 5, 2022
Initiates: Buy
Price Target: $30
Current: $1.03
Upside: +2,812.90%